These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19956815)

  • 1. Intrathecal analgesia in patients with cancer pain--an audit in a tertiary institution.
    Pasutharnchat K; Tan KH; Abdul Hadi M; Ho KY
    Ann Acad Med Singap; 2009 Nov; 38(11):943-6. PubMed ID: 19956815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
    Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
    Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
    Kiehelä L; Hamunen K; Heiskanen T
    Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study.
    Zheng S; He L; Yang X; Li X; Yang Z
    Medicine (Baltimore); 2017 Mar; 96(11):e6354. PubMed ID: 28296770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal intrathecal analgesia in refractory cancer pain.
    Mastenbroek TC; Kramp-Hendriks BJ; Kallewaard JW; Vonk JM
    Scand J Pain; 2017 Jan; 14():39-43. PubMed ID: 28850428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Intrathecal Analgesia With a Wireless Analgesia Pump System in the Home Care of Patients With Advanced Cancer.
    Liu HJ; Li WY; Chen HF; Cheng ZQ; Jin Y
    Am J Hosp Palliat Care; 2017 Mar; 34(2):148-153. PubMed ID: 26537661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of "refractory" nonmalignant pain.
    Nitescu P; Dahm P; Appelgren L; Curelaru I
    Clin J Pain; 1998 Mar; 14(1):17-28. PubMed ID: 9535310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal catheter-syringe adaptor for short-term intrathecal analgesia with an externalized pump: a case report.
    Wilkes D; Cook M; Solanki D
    Pain Physician; 2010; 13(2):151-6. PubMed ID: 20309381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near Death Experience from Placement of an Intrathecal Catheter.
    Padalia D; Jassal N; Patel S
    Pain Physician; 2016 May; 19(4):E621-3. PubMed ID: 27228528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal opioids for intractable pain syndromes.
    Koulousakis A; Kuchta J; Bayarassou A; Sturm V
    Acta Neurochir Suppl; 2007; 97(Pt 1):43-8. PubMed ID: 17691355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer.
    Gilmer-Hill HS; Boggan JE; Smith KA; Frey CF; Wagner FC; Hein LJ
    Surg Neurol; 1999 Jan; 51(1):6-11. PubMed ID: 9952116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous intrathecal opiate therapy with a portable drug pump in cancer pain].
    Motsch J; Bleser W; Ismaily AJ; Distler L
    Anasth Intensivther Notfallmed; 1988 Oct; 23(5):271-5. PubMed ID: 2907271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain.
    Rauck RL; Cherry D; Boyer MF; Kosek P; Dunn J; Alo K
    J Pain; 2003 Oct; 4(8):441-7. PubMed ID: 14622664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief review: Neuraxial analgesia in refractory malignant pain.
    Smyth CE; Jarvis V; Poulin P
    Can J Anaesth; 2014 Feb; 61(2):141-53. PubMed ID: 24233771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal pain pump infusions for intractable cancer pain: an algorithm for dosing without a neuraxial trial.
    Malhotra VT; Root J; Kesselbrenner J; Njoku I; Cubert K; Gulati A; Puttanniah V; Bilsky M; Kaplitt M
    Anesth Analg; 2013 Jun; 116(6):1364-70. PubMed ID: 23558833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for evaluating the use of intrathecal drug delivery in the oncologic patient.
    Gulati A; Puttanniah V; Hung J; Malhotra V
    Curr Pain Headache Rep; 2014 Feb; 18(2):391. PubMed ID: 24407749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer.
    Gestin Y; Vainio A; Pégurier AM
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 1):12-7. PubMed ID: 9061109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
    Brogan SE; Winter NB; Okifuji A
    Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.
    Deer TR; Smith HS; Burton AW; Pope JE; Doleys DM; Levy RM; Staats PS; Wallace MS; Webster LR; Rauck RL; Cousins M;
    Pain Physician; 2011; 14(3):E283-312. PubMed ID: 21587338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period.
    Mitchell A; McGhie J; Owen M; McGinn G
    Palliat Med; 2015 Jun; 29(6):554-63. PubMed ID: 25690600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.